Metagenomi Therapeutics (MGX) Share-based Compensation (2023 - 2026)
Metagenomi Therapeutics' Share-based Compensation was $2.27 million in Q2 2026, down 29.6% from $3.22 million a year earlier and down 11.1% from the prior quarter.
Powered by 
Analysis
Metagenomi Therapeutics (MGX) Share-based Compensation (2023 - 2026) Analysis & Trends
On a trailing twelve-month basis, Metagenomi Therapeutics' Share-based Compensation was $10.52 million through Jun 30, 2026, down 17.7% year-over-year; for FY2025, it came in at $11.85 million, down 26.9% from FY2024.
- In earlier years, Share-based Compensation was $16.2 million in FY2024 (+134.1%) and $6.92 million in FY2023.
- The Q2 2026 figure marks the lowest quarterly Share-based Compensation since Q2 2023.
- Compared with a year earlier, Share-based Compensation has declined for six straight quarters, with an average decline of 13.0% over the last eight quarters.
- The best year-over-year quarter for Share-based Compensation over five years was Q1 2024 (growth of 856.0%); the worst was Q1 2025 (a decline of 42.1%).
- Per Business Quant data, MGX's Share-based Compensation in the three quarters before Q2 2026 was $2.55 million (Q1 2026), $2.69 million (Q4 2025) and $3.01 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | - |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Metagenomi Therapeutics | 30.98 Mn | -574.76 Mn | - | 2.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.27 Mn |
| Mar 31, 2026 | 2.55 Mn |
| Dec 31, 2025 | 2.69 Mn |
| Sep 30, 2025 | 3.01 Mn |
| Jun 30, 2025 | 3.22 Mn |
| Mar 31, 2025 | 2.93 Mn |
| Dec 31, 2024 | 3.41 Mn |
| Sep 30, 2024 | 3.22 Mn |
| Jun 30, 2024 | 4.51 Mn |
| Mar 31, 2024 | 5.06 Mn |
| Dec 31, 2023 | 2.47 Mn |
| Sep 30, 2023 | 3.27 Mn |
| Jun 30, 2023 | 656,000.00 |
| Mar 31, 2023 | 529,000.00 |
API Access
Metagenomi Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=MGX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "MGX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=MGX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();